← Back to home

RELAPSED OR REFRACTORY LARGE B CELL LYMPHOMA, RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA, RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA

Clinical trials for RELAPSED OR REFRACTORY LARGE B CELL LYMPHOMA, RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA, RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY LARGE B CELL LYMPHOMA, RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA, RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY LARGE B CELL LYMPHOMA, RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA, RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New 'Ready-Made' cell therapy tested for tough blood cancers

Disease control Ongoing

This study is testing a new type of cell therapy called ALLO-501A for adults with large B-cell lymphoma or CLL/SLL that has come back or hasn't responded to other treatments. The goal is to see if this 'off-the-shelf' therapy, made from donor cells instead of the patient's own, i…

Matched conditions: RELAPSED OR REFRACTORY LARGE B CELL LYMPHOMA, RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA, RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Allogene Therapeutics • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

RELAPSED OR REFRACTORY LARGE B CELL LYMPHOMA, RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA, RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA

Get alerted when new RELAPSED OR REFRACTORY LARGE B CELL LYMPHOMA, RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA, RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA trials appear

New 'Ready-Made' cell therapy tested for tough blood cancers